Pine Labs Limited IPO: Issue Price, Listing Gain and Share Price Now
Pine Labs Limited listed on 14-Nov-2025 at ₹251.3 against an issue price of ₹221 , a listing gain of +13.71%. It last traded at ₹159.95. This page is the record of that issue and what has happened to it since — reported figures only.
Pine Labs Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹221 |
| Listing price (listing-day close) | ₹251.3 |
| Listing gain | +13.71% |
| Price now | ₹159.95 |
| Change from issue price | -27.62% |
| Change from listing-day close | -36.35% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Pine Labs Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹221 |
| Issue size | ₹3,899.91 Cr |
| Fresh issue | ₹2,080.12 Cr |
| Offer for sale | ₹1,819.79 Cr |
| Issue opened | 07-Nov-2025 |
| Issue closed | 11-Nov-2025 |
| Listed on | 14-Nov-2025 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | Axis Capital (left lead) |
How the Pine Labs Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 3.97x |
| NII | 0.30x |
| Retail | 1.27x |
| Total | 2.48x |
Pine Labs Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹18,427 Cr |
| Trailing P/E | 142.00x |
| Return on capital employed | 4.2% |
| Return on equity | 2.5% |
| 52-week high | ₹284 |
| 52-week low | ₹135 |
| Sector | Financial Technology (Fintech) |
Fundamentals are as of the desk's last harvest and move with the market.
- Pine Labs Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.